BTG3 and cardiac transplant: Similarly, nearly an eleven-fold enhanced risk for ABMR rejection was found in heart transplant recipients that were positive for ANA and had developed de novo IgG DSA (HR = 10.7, p = 1.25 x 10-10, Table 2), suggesting the synergistic effect of ANA and IgG dnDSA.